U.S. seizes discontinued eyelash product

WASHINGTON Sat Nov 17, 2007 10:53am IST

Related Topics

WASHINGTON (Reuters) - U.S. marshals on Friday seized 12,682 applicator tubes of a discontinued cosmetic called Age Intervention Eyelash, which the Food and Drug Administration said could harm some users' vision.

The product -- once promoted as increasing eyelash growth -- had been sold and distributed by San Jose, California-based Jan Marini Skin Research, Inc, which accused the FDA of unfairly singling it out.

The FDA said it considered Age Intervention Eyelash "adulterated" and potentially dangerous, notably for users with elevated pressure inside the eye.

The product contains bimatoprost, an active ingredient in an FDA-approved drug to treat this condition.

For patients on the prescription drug, using Age Intervention Eyelash may boost the risk of optic nerve damage "because the extra dose of bimatoprost may decrease the prescription drug's effectiveness," the FDA said.

Jan Marini, the company's president and chief executive, said the product at issue had been in its warehouse since September 2006, when California public health authorities "embargoed" it at FDA request.

The company added in a statement it had offered to destroy the product, "but the FDA recently informed JMSR that it preferred to seize the product so that it could issue a press release announcing the seizure."

"We have been unfairly singled out," Marini said in a telephone interview. "Other companies use the same ingredient and we're not aware of any action that has been taken against them."

FDA spokesman Brad Swezey said in response, "As a matter of policy, we can't acknowledge whether any company is or is not the subject of an ongoing investigation."

The company said it had reformulated its eyelash product a year ago to eliminate the ingredient questioned by the FDA and had scrapped its marketing claims.

In its statement, the FDA said the sales value of the seized tubes was about $2 million and the marshals acted at the FDA's request.

Consumers, dermatologists and beauticians who may still have Age Intervention Eyelash should discontinue using it and discard it, FDA said.

It recommended consumers consult health-care providers if they have experienced any problems they suspect are related to the product's use.

"The agency takes seriously its responsibility to protect Americans from unapproved drugs," the statement said.

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Ebola Outbreak

REUTERS SHOWCASE

Islamic State

Islamic State

Iraqi security forces and Kurds gain ground against Islamic State  Full Article 

Brazil Votes

Brazil Votes

Brazil votes in tight presidential runoff split along class lines  Full Article 

School Shooting

School Shooting

Washington state teen shooter's family living in 'nightmare'   Full Article 

Canada Attacks

Canada Attacks

Canadians flock to Parliament Hill, site of attack on soldier  Full Article 

Abe's Ratings

Abe's Ratings

Japanese PM Abe's public support slumps in wake of resignations - poll  Full Article 

New World Record

New World Record

Google executive sets new stratosphere skydive world record  Full Article 

Bollywood World

Bollywood World

Read stories and reviews Bollywood films.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage